Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Excess mortality reveals infection speed in COVID-19 is low with seasonal infection patterns and escape variants

Researchers from the University of Wurzburg in Germany have been attempting to create a new method for determining the R0 using excess mortality data.

17 Nov 2021

Game animals as potential drivers of disease emergence

A study characterized the total virome of game animals from five mammalian orders using the total RNA sequencing technique.

17 Nov 2021

Urinary SARS-CoV-2 RNA is a prognosticator of COVID-19

A new study published in the journal Diagnostics was based on the hypothesis that detecting urinary SARS-CoV-2 nucleic acid––which may result in renal and cardiovascular endothelial destruction to facilitate viral access to the kidney parenchyma—may be used as a specific biomarker to indicate the severity of COVID-19.

16 Nov 2021

A therapeutic interfering particle for SARS-CoV-2

Researchers report their attempt to engineer TIPs that can conditionally replicate with SARS-CoV-2, inhibit viral replication 10–100 fold, and exhibit R0>1.

16 Nov 2021

More than 13 million people in the UK received COVID-19 booster jabs

More than 13 million life-saving booster jabs have been given across the UK, marking another significant milestone in the phenomenal COVID-19 vaccination programme.

16 Nov 2021

Targeted proteomics for detection of SARS-CoV-2 proteins in clinical samples

A team of researchers from various institutions within the Netherlands examined the use of targeted MS-based proteomics for the detection of SARS-CoV-2 in research and clinical samples.

16 Nov 2021

Study reveals racial, ethnic disparities in mortality rates for common conditions among VA patients

A study of Veterans hospitalized for common conditions in the Veterans Affairs (VA) healthcare system confirms that adjusted mortality rates are lower for Black compared to White Veterans – while also showing higher adjusted mortality rates among Hispanic Veterans relative to White Veterans across most risk-adjustment models, reports the December issue of Medical Care.

15 Nov 2021

Promising results from Phase II REGEN-COV study

Initial results of the REGEN-COV Phase II study are presented.

15 Nov 2021

Prescription omega-3 pill did not reduce hospitalization or death from COVID-19

A high dose of a purified omega-3 fatty acid, available by prescription only, was well tolerated; however, it did not substantially reduce incidents of hospitalizations and/or deaths among people with COVID-19, according to a late-breaking clinical trial presented today at the American Heart Association's Scientific Sessions 2021.

15 Nov 2021

Anti-platelet drug class fails to extend survival in moderately ill COVID-19 patients

A drug class that blocks the activity of blood platelets and prevents clotting—P2Y12 inhibitors—failed to extend survival or lessen disease severity in patients with COVID-19 who were hospitalized but had a relatively moderate case, a new study finds.

15 Nov 2021

New therapy targets rodents' cells rather than bacterial cells in treating pneumonia

Researchers at the National Institutes of Health have discovered a therapy that targets host cells rather than bacterial cells in treating bacterial pneumonia in rodents.

15 Nov 2021

SARS-CoV-2 infection inhibited by CCR2 signaling

A new study discusses the role of monocytes in protecting individuals from SARS-CoV-2.

15 Nov 2021

Benefits of vaccine mandates and vaccine passports for SARS-CoV-2

A new study has been published that evaluates the benefits of VMVP by estimating the benefits of vaccination and exclusion of unvaccinated people from different settings.

15 Nov 2021

Vaccination protects against COVID-19 related hospitalization in patients with and without comorbidity

Researchers from University Medical Centre Utrecht have been investigating the efficiency of vaccines against the alpha variant in the Netherlands.

15 Nov 2021

Public health strategies associated with reduced SARS-CoV-2 transmission in Switzerland

The current study attempts to estimate the quantitative effects of specific measures, using a combination of phylogenetic and phylodynamic approaches.

15 Nov 2021

New formulation for treating diabetic foot ulcers could also be used to kill COVID-19 virus

A new formulation developed by University of South Australia scientists to treat antimicrobial-resistant bacterial infections in diabetic foot ulcers could also be used to kill the COVID-19 virus circulating in air conditioning systems.

15 Nov 2021

Mycobacterium tuberculosis may induce resistance to secondary SARS-CoV-2 infection

The current study reveals that mice infected with mycobacterium tuberculosis are resistant to SARS-CoV-2 infection.

14 Nov 2021

A non-mechanistic approach to real-time forecasting of U.S. COVID-19 pandemic

A new study introduces the non-mechanistic MIT-LCP forecasting model and compares its performance to other models for forecasting COVID-19 dynamics.

14 Nov 2021

Study assesses whether medicinal mushrooms and Chinese herbs can help treat COVID-19

A novel study is assessing whether medicinal mushrooms and Chinese herbs provide therapeutic benefit in treating acute COVID-19 infection.

12 Nov 2021

Potential therapeutic targets of hydrogen for treatment of the COVID-19

A recent article provided a review of a study led by academician Zhong Nanshan, in China, on COVID-19 treatment by inhalation of a mixed gas composed of hydrogen and oxygen.

12 Nov 2021

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Excess mortality reveals infection speed in COVID-19 is low with seasonal infection patterns and escape variants

Game animals as potential drivers of disease emergence

Urinary SARS-CoV-2 RNA is a prognosticator of COVID-19

A therapeutic interfering particle for SARS-CoV-2

More than 13 million people in the UK received COVID-19 booster jabs

Targeted proteomics for detection of SARS-CoV-2 proteins in clinical samples

Study reveals racial, ethnic disparities in mortality rates for common conditions among VA patients

Promising results from Phase II REGEN-COV study

Prescription omega-3 pill did not reduce hospitalization or death from COVID-19

Anti-platelet drug class fails to extend survival in moderately ill COVID-19 patients

New therapy targets rodents' cells rather than bacterial cells in treating pneumonia

SARS-CoV-2 infection inhibited by CCR2 signaling

Benefits of vaccine mandates and vaccine passports for SARS-CoV-2

Vaccination protects against COVID-19 related hospitalization in patients with and without comorbidity

Public health strategies associated with reduced SARS-CoV-2 transmission in Switzerland

New formulation for treating diabetic foot ulcers could also be used to kill COVID-19 virus

Mycobacterium tuberculosis may induce resistance to secondary SARS-CoV-2 infection

A non-mechanistic approach to real-time forecasting of U.S. COVID-19 pandemic

Study assesses whether medicinal mushrooms and Chinese herbs can help treat COVID-19

Potential therapeutic targets of hydrogen for treatment of the COVID-19

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in